Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Apr 30:1:13.
doi: 10.1186/1752-1947-1-13.

Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report

Affiliations

Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report

Graham M Cormack et al. J Med Case Rep. .

Abstract

Thrombocytopenia commonly occurs in hospitalized patients, particularly critically ill patients. We present an exemplifying case of severe heparin-induced thrombocytopenia (HIT) in an effort to solidify its high priority in the differential diagnosis of thrombocytopenia. A 75-year-old female underwent cardiac surgery with intraaortic balloon pump (IABP) placement. A platelet count drop to 25 x 10(9)/L by the third postoperative day was attributed to the IABP, which was removed. Her thrombocytopenia remained refractory to multiple platelet transfusions over several days. Right hand cyanosis then developed, attributed to a right radial arterial catheter, which was removed. All toes and fingers then showed severe ischemic changes. Ten days after the initial platelet count drop, a critical care specialist new to the treating team suspected HIT. Heparin exposure was stopped and argatroban was initiated. A HIT antibody test was subsequently strongly positive. The patients thrombocytopenia gradually resolved. No additional thromboses occurred during a 27-day intensive care unit stay. This case underscores the need for vigilance in suspecting HIT in patients with thrombocytopenia and recent heparin exposure. To avoid catastrophic outcomes in such patients, heparin should be stopped and alternative anticoagulation should be initiated, at least until HIT is excluded.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gangrenous right hand and left foot as they appeared on hospital day #15.
Figure 2
Figure 2
Platelet counts and key clinical events during hospitalization.

References

    1. Campbell KR, Mahaffey KW, Lewis BE, et al. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invas Cardiol. 2000;12:14F–19F. - PubMed
    1. Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005;111:2671–2683. doi: 10.1161/CIRCULATIONAHA.104.518563. - DOI - PubMed
    1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:311S–337S. doi: 10.1378/chest.126.3_suppl.311S. - DOI - PubMed
    1. Rice L. Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient) Arch Intern Med. 2004;164:1961–1964. doi: 10.1001/archinte.164.18.1961. - DOI - PubMed
    1. Harenberg J, Huhle G, Giese C, et al. Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol. 2000;109:182–186. doi: 10.1046/j.1365-2141.2000.01966.x. - DOI - PubMed

LinkOut - more resources